PET/CT Quantitative Assessment of Myocardial Blood Flow Changes in Oncologic Patients Receiving Checkpoint Inhibitor Therapy

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

August 14, 2020

Primary Completion Date

May 19, 2022

Study Completion Date

May 19, 2022

Conditions
Cancer
Interventions
DIAGNOSTIC_TEST

PET/CT

Positron emission tomography-computed tomography is an image test that helps show detail about how tissues and organs are functioning.

DRUG

radioactive drug (tracer)

A radioactive drug (tracer) is used in the PET scan.

Trial Locations (1)

55905

Mayo Clinic in Rochester, Rochester

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Mayo Clinic

OTHER

NCT04538950 - PET/CT Quantitative Assessment of Myocardial Blood Flow Changes in Oncologic Patients Receiving Checkpoint Inhibitor Therapy | Biotech Hunter | Biotech Hunter